Rate My Professor Chen Liu

Chen Liu, MD, PhD, is the Anthony N. Brady Professor of Pathology, Chair of the Department of Pathology at Yale School of Medicine, and Chief of Pathology at Yale New Haven Hospital. He received his medical degree from Tong Liao Medical College in 1980 and another MD from Tongji Medical University in 1985, followed by a PhD in pathology from the University of Pennsylvania School of Medicine in 1993. He completed an internship and residency in anatomical and clinical pathology at the Medical College of Pennsylvania in 1997 and 1999, an oncological pathology fellowship at the University of Texas MD Anderson Cancer Center in 2000, and postdoctoral training at Scripps Clinic. Postgraduate training was undertaken at Peking Union Medical College in China.

Dr. Liu's distinguished career includes faculty appointments at the University of Florida's Department of Pathology, Immunology, and Laboratory Medicine, where he advanced to endowed professor and vice chair. From 2015 to 2020, he served as joint chair of the Department of Pathology, Immunology, and Laboratory Medicine at New Jersey Medical School and Robert Wood Johnson Medical School at Rutgers University, chief of pathology services at University Hospital in Newark and RWJ University Hospital in New Brunswick, and chief of the Division of Oncological Pathology at the Rutgers Cancer Institute of New Jersey. Recruited to Yale in 2020, he leads the department. A renowned gastrointestinal and liver pathologist, his research centers on viral hepatitis, liver cancer immunotherapy, graft-versus-host disease, and cancer epigenetics, investigating virus- or alcohol-induced carcinogenesis, cancer biomarkers, and therapies with small molecules and immunotherapy. He has authored over 240 peer-reviewed articles and book chapters, holds five patents, and maintains continuous funding from the National Institutes of Health. Select publications include "Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models" (Journal of Clinical Investigation, 2024), "Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage" (Journal of Clinical Investigation, 2024), "STAT1 regulates immune-mediated intestinal stem cell proliferation and epithelial regeneration" (Nature Communications, 2025), and "Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation" (Immunity, 2023).